Hopwood, J; Whitley, C; Waber, L; Pais, R; Steiner, R; Plecko, B; Kaplan, P; Simon, J; Waterson, J; Harmatz, P.
A phase I/II randomized, double blind, two dose group study of recombinant human N-acetylgalactosamine-4-sulfatase (rhASB) enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): 96 week progress report.
AMER J HUM GENET 2003 73: 200-200.
Web of Science